EPZ011989 - ≥97% , CAS No.2095432-26-9

CAS: 2095432-26-9 Cat. No.: E413837 分子式: C35H51N5O4·HCl 分子量: 642.27
注文可能
GRADE & PURITY ≥97%
Synonyms
N-​[(1,​2-​dihydro-​4,​6-​dimethyl-​2-​oxo-​3-​pyridinyl)​methyl]​-​3-​[ethyl[trans-​4-​[(2-​methoxyethyl)​methylamino]​cyclohexyl]​amino]​-​2-​methyl-​5-​[3-​(4-​morpholinyl)​-​1-​propyn-​1-​yl]​-benzamide hydrochloride
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
USA
ドイツ (EU)*
Price
Qty
5mg
E413837-5mg
受注生産 · 8~12週間

$222.90

$259.90
保存 $37.00 (14.24%)
25mg
E413837-25mg
受注生産 · 8~12週間
$793.90
100mg
E413837-100mg
受注生産 · 8~12週間

$1,550.90

$1,809.90
保存 $259.00 (14.31%)
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥97% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

概要

Information

EPZ011989 EPZ011989 is a potent, selective, orally bioavailable EZH2 inhibitor with K i of <3 nM.


Targets

EZH2 (Cell-free assay); EZH1 (Cell-free assay) <3 nM(Ki); 103 nM


In vitro

EPZ011989 equipotently inhibits mutant and wild-type EZH2 with an inhibition constant (Ki) of <3 nM. EPZ011989 is also a specific EZH2 inhibitor with a >15-fold selectivity over EZH1 and >3000-fold selectivity relative to the Ki of 20 other histone methyltransferases (HMTs) tested. As evidenced by the human and rat liver microsomal turnover, EPZ011989 also exhibits metabolic stability. EPZ011989 reduces cellular H3K27 methylation in the Y641F, mutant-bearing human lymphoma cell line, WSU-DLCL2, with an IC50 below 100 nM. EPZ011989 inhibits H3K27me3 in wild-type EZH2 AML cell lines (Kasumi-1, MOLM-13, and MV4-11) at a concentration of 0.625 μM after only four days of treatment. At these concentrations and this time point, no change in viability among these three cell lines is observed and only minimal proliferation inhibition in MV4-11 and MOLM-13 cells.


In vivo

EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenograft model of human B cell lymphoma. EPZ011989 is able to elicit robust methyl mark inhibition and antitumor activity.


Cell Research(from reference)

Cell lines:WSU-DLCL2 cells 

Concentrations:0-10 μM 

Incubation Time:0-11 days 

Specifications

同義語
N-​[(1,​2-​dihydro-​4,​6-​dimethyl-​2-​oxo-​3-​pyridinyl)​methyl]​-​3-​[ethyl[trans-​4-​[(2-​methoxyethyl)​methylamino]​cyclohexyl]​amino]​-​2-​methyl-​5-​[3-​(4-​morpholinyl)​-​1-​propyn-​1-​yl]​-benzamide hydrochloride
仕様と純度
≥97%
生化学的・生理学的メカニズム
EPZ011989 is a potent, selective, orally bioavailable EZH2 inhibitor with Ki of <3 nM.
保管条件
Store at -20°C
入荷
Ice chest + Ice pads
この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。
アクションタイプ
INHIBITOR
純度
≥97%
名前と識別子
分子量 642.27

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
化学的性質と物理的性質
溶解度Solubility (25°C) In vitro Ethanol: 100 mg/mL (155.69 mM); DMSO: Insoluble; Water: Insoluble;
ソリューション計算機
レビュー

顧客レビュー

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.